LC
SRGA

Lindbrook Capital’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Lindbrook Capital’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24
Closed -$1K – 2054
2021
Q2 		$1K Buy
+24
New +$1.23K ﹤0.01% 1889

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's SRGA Position: Q3 2021 in Review

Lindbrook Capital sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2021, closing a stake of 24 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in SRGA in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2021.

  • Lindbrook Capital reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Lindbrook Capital sold 24 Surgalign Holdings, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Lindbrook Capital first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Lindbrook Capital's Surgalign Holdings, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2021.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.